Programme per day (in SAST)
Monday 2 September 2024
APMO-01 FIP Foundation Programme
Meeting room 1.60
Celebrate the FIP Foundation good work and meet the 2023-24 Research Grant recipients and leadership scholars
The FIP Foundation Board will present a brief report on our programme successes with and share our future ...
Read more
EMMO-01 Early morning symposium: Experiences and practical tools for supporting the role of pharmacists in the prevention and management of long-term conditions
Ballroom West
This session will address how pharmacists can support individuals with risk factors to prevent or delay the onset of long-term conditions, or to prevent exacerbations or the aggravation of the disease. This can be ...
Read more
MOMO-01 Sharing ideas of member organisations: The Swiss Association of Pharmacists (pharmaSuisse) & Royal Dutch Pharmacists Association (KNMP)
Meeting room 2.40
FIP member organisations will present their best initiatives and challenges.
Read more
MOMO-02 Sharing ideas of member organisations: Association of Pharmacists Belgium & European Association of Hospital Pharmacists
Meeting room 2.60
FIP member organisations will present their best initiatives and challenges.
Read more
MOMO-03 Sharing ideas of member organisations: Order of Pharmacists of Lebanon & Egyptian Organization of Pharmacy (EOP)
Roof Terrace room
FIP member organisations will present their best initiatives and challenges.
Read more
PLMO-01 Plenary session -Equitable quality health care: A call to action for pharmacy
Auditorium
This session will delve into current healthcare disparities, focusing on equitable and quality health care and the essential role of pharmacy. Global perspectives, successful strategies and pharmacy-led initiatives will ...
Read more
Coffee and tea break
PSMO-01 Data integration and interoperability for the modern pharmacist
Auditorium
Pharmacists’ roles are continuously evolving, and staying abreast of technological advancements is crucial for providing the best care to patients. This session will delve into how data integration is revolutionising ...
Read more
PSMO-02 Innovation in supply chain of health commodities: Pharmacists role in equitable and affordable access to medicines and medical devices
Ballroom East
Access to medicines is recognised as a fundamental human right. However, the 2022 World Health Organization report highlights that about one-third of the world’s population (2.5 billion people) lack access to quality ...
Read more
PSMO-03 International humanitarian law: Access to medicines
Ballroom West
Conflict plays a major role in humanitarian response. Protracted crisis, such as those in Syria and Yemen dominate the humanitarian case load while also threatening the humanitarian space. In additional to protracted ...
Read more
PSMO-04 Planetary health: Contributions from pharmacy
Meeting room 1.60
Planetary health is defined as the health of human civilisation and the state of the natural systems on which it depends. The health of people has been improving gradually across the world, but it caused extensive ...
Read more
PSMO-05 HIV treatment: The future of preventative care and management
Meeting room 2.40
Approximately 38 million people worldwide are living with HIV, with 75% receiving antiretroviral treatment. New HIV infections have fallen by 40% since the peak in 1988. The World Health Organization aims to reduce ...
Read more
PSMO-06 The evolving role of pharmacists in increasing access to treatment and health outcomes in South Africa and globally
Meeting room 2.60
This session looks at the expanded role of pharmacists in increasing the accessibility of primary health care through task-shifting and improved service offerings to patients. In South Africa, the mass COVID-19 vaccine ...
Read more
RFMO-07 Rapid fire session from selected oral abstracts
Lunch break (poster viewing and expo visit)
LSMO-04 Lunch break symposium: Role of Pharmacists and HCPs in HPV-related diseases elimination (Supported by MSD)
Meeting room 2.60
Educate and inform the audience of the role and the importance of the Pharmacy and Pharmacist and HCP in the prevention and elimination of HPV related cancers in diseases in females and males.
Read more
LSMO-01 Lunch break symposium: Role of quality-of-life in driving superior patient outcomes in self-care (Supported by Haleon)
Meeting room 1.60
A scientific forum on the importance of supporting quality of life as part of treatment goals for sufferers of the common cold and osteoarthritis using real world data as evidence.
Read more
LSMO-02 Lunch break symposium: A new paradigm: Expanding pharmacists’ role in vaccination to support public health (Supported by Pfizer)
LSMO-03 Lunch break symposium: Coercion or custodian: A lively debate (GRIP)
Roof Terrace room
The session takes a debate format where one team is a proponent for ‘bottom-up’ or community pharmacy driven behaviour change and the other team is a proponent for ‘top-down’ or legislative change being most ...
PSMO-08 Digital health biomarkers: Revolutionising screening, illness follow-up and medication monitoring for enhanced efficacy and safety
Auditorium
This session will appeal to a wide array of stakeholders within the pharmacy field. Pharmacists are interested in learning how digital health biomarkers can streamline medication management, facilitate screening, and ...
Read more
PSMO-09 Global impact, local solutions: Pharmacists tackling antimicrobial resistance (AMR) in low-resource settings
Ballroom East
This session will highlight pharmacist-led antimicrobial stewardship initiatives in resource-limited settings aimed at tackling antimicrobial resistance. It will outline key programmes in LMICs, including the ...
Read more
PSMO-10 New strategies for pharmacists in the fight against substandard and falsified drugs
Ballroom West
During a time when substandard and falsified (SF) medicines continue to threaten patient safety and public health, pharmacists play a role as the last line of defense for patients. SF medicines impact the quality of ...
Read more
PSMO-11 Accelerating practice innovation: Closing the health security inequality gap
Meeting room 1.60
The World Health Organization defines global public health security as the set of activities that minimise risk and negative impact of acute public health events which put people’s health in danger across geographical ...
Read more
PSMO-12 Computational modelling and simulation: Challenges and opportunities for FIP
Meeting room 2.40
Computational modelling and simulation to understand exposure-response relationships of medicines has emerged as a firmly established discipline that has ushered in an era of model-informed drug development and ...
Read more
PSMO-13 Risk-based approach to compliance — Ensuring quality and safety in healthcare services
Meeting room 2.60
The pharmaceutical value chain operates under various sets of quality and regulatory standards that apply from manufacturing until medicines are dispensed. Adherence to these standards is further monitored by various ...
Read more
RFMO-14 Rapid fire session from selected oral abstracts
Coffee and tea break
PLMO-02 Plenary session – Innovative drug discovery and access
Auditorium
This plenary session on innovative drug discovery and access will address current challenges, integrating industry-driven innovation with patient-centric clinical trials. A panel discussion titled, “Pharmacy’s ...
Read more
Section dinners
Dinners organised for the following sections:
Academic Pharmacy Section dinner
Clinical Biology Section dinner
Community Pharmacy Section dinner
Health and Medicines Information dinner
Hospital Pharmacy ...
Read more